No. 4 Medical Innovation for 2018: The Unprecedented Reduction of LDL Cholesterol (Video)
The unprecedented reduction of LDL cholesterol will be the No. 4 most influential medical innovation for 2018, predict experts at Cleveland Clinic.
Low-density lipoprotein (LDL), or “bad” cholesterol, causes fatty deposits that can clog arteries. But certain new drug combinations can reduce LDL levels by 75 percent.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New studies have reported that patients with ultra-low LDL from taking statins combined with a new class of cholesterol-lowering drugs (PCSK9 inhibitors) have a 20 percent lower risk of cardiovascular death, myocardial infarction or stroke.
In this video, learn more about why the unprecedented reduction of LDL cholesterol is No. 4 on Cleveland Clinic’s list of Top 10 Medical Innovations for 2018.